1-((4S)-2-(4-FLUORO-3,5-DIMETHYLPHENYL)-4,5,6,7-TETRAHYDRO-4-METHYL-2H-PYRAZOLO(4,3-C)PYRIDIN-3-YL)-3-(4-FLUORO-1-METHYL-1H-INDAZOL-5-YL)-1,3-DIHYDRO-2H-IMIDAZOL-2-ONE
UNII 4MY4T3LE4R
Substance Identification & Data
This profile provides standardized clinical and technical data for 1-((4s)-2-(4-fluoro-3,5-dimethylphenyl)-4,5,6,7-tetrahydro-4-methyl-2h-pyrazolo(4,3-c)pyridin-3-yl)-3-(4-fluoro-1-methyl-1h-indazol-5-yl)-1,3-dihydro-2h-imidazol-2-one, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4MY4T3LE4R.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2212022-56-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C26H25F2N7O RUAXBTGNBAFEOY-INIZCTEOSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 1-((4s)-2-(4-fluoro-3,5-dimethylphenyl)-4,5,6,7-tetrahydro-4-methyl-2h-pyrazolo(4,3-c)pyridin-3-yl)-3-(4-fluoro-1-methyl-1h-indazol-5-yl)-1,3-dihydro-2h-imidazol-2-one. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.